Preservation of gray matter volume in multiple sclerosis patients with the Met allele of the rs6265 (Val66Met) SNP of brain-derived neurotrophic factor.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Human Molecular Genetics

• Publication date

  2007-11-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/HMG/DDM189PMID 17656372
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Investigating the role of brain‐derived neurotrophic factor in relapsing–remitting multiple sclerosis

  2007influential reference
• Validity of the Wisconsin Card Sorting and Delis–Kaplan Executive Function System (DKEFS) Sorting Tests in multiple sclerosis

  2007cited by this paper
• Diffusion-weighted imaging predicts cognitive impairment in multiple sclerosis

  2007cited by this paper
• Cognitive impairment in patients with multiple sclerosis: association with the APOE gene and promoter polymorphisms

  2007cited by this paper
• Differential expression of BDNF mRNA splice variants in mouse brain and immune cells.

  2007cited by this paper
• Production of brain-derived neurotrophic factor by mononuclear cells of patients with multiple sclerosis treated with glatiramer acetate, interferon-β 1a, and high doses of immunoglobulins

  2007cited by this paper
• I nterferon beta-1a slows progression of brain atrophy in relapsing-remitting multiple sclerosis predominantly by reducing gray matter atrophy

  2007influential reference
• Interferon-beta regulates cytokines and BDNF: greater effect in relapsing than in progressive multiple sclerosis.

  2007cited by this paper
• Quantitative diffusion weighted imaging measures in patients with multiple sclerosis

  2007cited by this paper
• Interferon-β regulates cytokines and BDNF: greater effect in relapsing than in progressive multiple sclerosis

  2007cited by this paper
• Gray matter involvement in multiple sclerosis

  2007cited by this paper
• Evidence for a direct association between cortical atrophy and cognitive impairment in relapsing-remitting MS

  2006cited by this paper
• No association of the Val66Met polymorphism of brain-derived neurotrophic factor (BDNF) to multiple sclerosis.

  2006cited by this paper
• The Met66 allele of the functional Val66Met polymorphism in the brain-derived neurotrophic factor gene confers protection against neurocognitive dysfunction in systemic lupus erythematosus

  2006cited by this paper
• MRI T2 lesion burden in multiple sclerosis

  2006cited by this paper
• The neuroprotective effect of inflammation: implications for the therapy of multiple sclerosis

  2006cited by this paper
• Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS)

  2006influential reference
• Genetic variants in brain-derived neurotrophic factor associated with Alzheimer’s disease

  2006cited by this paper
• Interferon beta promotes nerve growth factor secretion early in the course of multiple sclerosis.

  2005cited by this paper
• Lower brain-derived neurotrophic factor in serum of relapsing remitting MS: reversal by glatiramer acetate.

  2005cited by this paper
• The BDNF-Val66Met polymorphism: implications for susceptibility to multiple sclerosis and severity of disease.

  2005cited by this paper
• The Brain-Derived Neurotrophic Factor val66met Polymorphism and Variation in Human Cortical Morphology

  2004cited by this paper
• Relapsing and remitting multiple sclerosis: Pathology of the newly forming lesion

  2004cited by this paper
• Brain-derived neurotrophic factor, apolipoprotein E genetic variants and cognitive performance in Alzheimer's disease.

  2004cited by this paper
• Working memory and processing speed deficits in systemic lupus erythematosus as measured by the paced auditory serial addition test

  2004cited by this paper
• Early Striatal Dendrite Deficits followed by Neuron Loss with Advanced Age in the Absence of Anterograde Cortical Brain-Derived Neurotrophic Factor

  2004cited by this paper
• Variant Brain-Derived Neurotrophic Factor (BDNF) (Met66) Alters the Intracellular Trafficking and Activity-Dependent Secretion of Wild-Type BDNF in Neurosecretory Cells and Cortical Neurons

  2004cited by this paper
• Mapping the neural systems that mediate the Paced Auditory Serial Addition Task (PASAT)

  2004cited by this paper
• Accelerated evolution of brain atrophy and “black holes” in MS patients with APOE‐ε4

  2004cited by this paper
• Prediction of neuropsychological impairment in multiple sclerosis: comparison of conventional magnetic resonance imaging measures of atrophy and lesion burden.

  2004cited by this paper
• Reliable screening for neuropsychological impairment in multiple sclerosis

  2004cited by this paper
• Correlating Brain Atrophy With Cognitive Dysfunction, Mood Disturbances, and Personality Disorder in Multiple Sclerosis

  2004cited by this paper
• Association between a polymorphism of brain‐derived neurotrophic factor gene and sporadic Parkinson's disease

  2003cited by this paper
• Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia

  2003cited by this paper
• Brain-Derived Neurotrophic Factor val66met Polymorphism Affects Human Memory-Related Hippocampal Activity and Predicts Memory Performance

  2003influential reference
• Toward identification of susceptibility genes for sporadic Parkinson’s disease

  2003cited by this paper
• Cognitive performance and MR markers of cerebral injury in cognitively impaired MS patients

  2003cited by this paper
• Frontal cortex BDNF levels correlate with working memory in an animal model of Down syndrome.

  2003cited by this paper
• A paced visual serial addition test for fMRI.

  2003cited by this paper
• The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function.

  2003influential reference
• Sequence variants of the brain-derived neurotrophic factor (BDNF) gene are strongly associated with obsessive-compulsive disorder.

  2003cited by this paper
• Glutamate uptake by oligodendrocytes

  2003cited by this paper
• Brain-derived neurotrophic factor in patients with multiple sclerosis.

  2002cited by this paper
• Association of a null mutation in the CNTF gene with early onset of multiple sclerosis.

  2002cited by this paper
• Association studies of multiple candidate genes for Parkinson's disease using single nucleotide polymorphisms

  2002cited by this paper
• Association of polymorphisms in the apolipoprotein E region with susceptibility to and progression of multiple sclerosis.

  2002cited by this paper
• Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus

  2002cited by this paper
• Multiple sclerosis functional composite: impact of reference population and interpretation of changes

  2002cited by this paper
• Minimal Neuropsychological Assessment of MS Patients: A Consensus Approach

  2002cited by this paper
• Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Brain-derived neutrophic factor.

  2002cited by this paper
• Brain-derived Neurotrophic Factor Regulates Surface Expression of α-Amino-3-hydroxy-5-methyl-4-isoxazoleproprionic Acid Receptors by Enhancing the N-Ethylmaleimide-sensitive Factor/GluR2 Interaction in Developing Neocortical Neurons*

  2002cited by this paper
• The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder: evidence from a family-based association study.

  2002cited by this paper
• BDNF and gp145trkB in multiple sclerosis brain lesions: neuroprotective interactions between immune and neuronal cells?

  2002cited by this paper
• A null mutation in the CNTF gene is not associated with early onset of multiple sclerosis.

  2002cited by this paper
• Accurate, Robust, and Automated Longitudinal and Cross-Sectional Brain Change Analysis

  2002cited by this paper
• Effects of IV methylprednisolone on brain atrophy in relapsing-remitting MS

  2001cited by this paper
• Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis

  2001cited by this paper
• Normalized Accurate Measurement of Longitudinal Brain Change

  2001cited by this paper
• Loss of Huntingtin-Mediated BDNF Gene Transcription in Huntington's Disease

  2001cited by this paper
• Genetic influences on brain structure

  2001cited by this paper
• Glutamate excitotoxicity--a mechanism for axonal damage and oligodendrocyte death in Multiple Sclerosis?

  2000cited by this paper
• Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination

  2000cited by this paper
• The neuroprotective effect of inflammation: implications for the therapy of multiple sclerosis.

  2000cited by this paper
• NG2-Positive Oligodendrocyte Progenitor Cells in Adult Human Brain and Multiple Sclerosis Lesions

  2000cited by this paper
• Up-regulated p75NTR neurotrophin receptor on glial cells in MS plaques

  1999cited by this paper
• Trophic regulation of synaptic plasticity.

  1999cited by this paper
• Activated Human T Cells, B Cells, and Monocytes Produce Brain-derived Neurotrophic Factor In Vitro and in Inflammatory Brain Lesions: A Neuroprotective Role of Inflammation?

  1999cited by this paper
• AXONAL TRANSECTION IN THE LESIONS OF MULTIPLE SCLEROSIS

  1998cited by this paper
• Axonal transection in the lesions of multiple sclerosis.

  1998cited by this paper
• Awareness of remembering achieved through automatic and conscious processes in multiple sclerosis.

  1998cited by this paper
• Apolipoprotein E polymorphism and silent microangiopathy-related cerebral damage. Results of the Austrian Stroke Prevention Study.

  1997cited by this paper
• PolyPhred: automating the detection and genotyping of single nucleotide substitutions using fluorescence-based resequencing.

  1997cited by this paper
• Interferon‐β Is a Potent Promoter of Nerve Growth Factor Production by Astrocytes

  1997cited by this paper
• Revision of the Brief Visuospatial Memory Test: Studies of normal performance, reliability, and validity.

  1996cited by this paper
• Clinical outcomes assessment in multiple sclerosis

  1996cited by this paper
• Short technical reports. Modification of the TRI reagent procedure for isolation of RNA from polysaccharide- and proteoglycan-rich sources.

  1995cited by this paper
• Cognitive dysfunction in multiple sclerosis.

  1991cited by this paper
• Predicting premorbid IQ: A revision of the national adult reading test

  1989cited by this paper
• Paced Auditory Serial-Addition Task: A Measure of Recovery from Concussion

  1977influential reference

• BDNF levels in serum and CSF are associated with clinicoradiological characteristics of aggressive disease in MS patients

  2025cites this paper
• Effect of Cognitive Impairments in Multiple Sclerosis on Caregivers’ Quality of Life: A Review

  2025cites this paper
• Neurotrophic factors in multiple sclerosis

  2025cites this paper
• The relevance of BDNF for neuroprotection and neuroplasticity in multiple sclerosis

  2024cites this paper
• Genetic Variability in Oxidative Stress, Inflammatory, and Neurodevelopmental Pathways: Impact on the Susceptibility and Course of Spinal Muscular Atrophy

  2024cites this paper
• Lack of Association between BDNF rs6265 and Multiple Sclerosis: A Case–Control Study

  2024cites this paper
• The Influence of Conventional and Innovative Rehabilitation Methods on Brain Plasticity Induction in Patients with Multiple Sclerosis

  2023cites this paper
• Molecular biomarkers and cognitive impairment in multiple sclerosis: state of the field, limitations, and future direction - A systematic review and meta-analysis.

  2023cites this paper
• [BDNF gene RS6265 polymorphism in patients with multiple sclerosis of Tomsk region].

  2023cites this paper
• Association of the BDNF rs6265 Polymorphism with Cognitive Impairment in Multiple Sclerosis: A Case–Control Study in Mexican Patients

  2023influential citation
• New Frontiers in Neurodegeneration and Regeneration Associated with Brain-Derived Neurotrophic Factor and the rs6265 Single Nucleotide Polymorphism

  2022cites this paper
• Ketogenic and Modified Mediterranean Diet as a Tool to Counteract Neuroinflammation in Multiple Sclerosis: Nutritional Suggestions

  2022cites this paper
• Study on the Relationship between 5-HttLPR Gene and BDNF Gene Polymorphism and Post-Traumatic Stress Disorder in Li and Han Nationality of Hainan Province

  2022cites this paper
• The BDNF Val66Met Polymorphism (rs6265) Modulates Inflammation and Neurodegeneration in the Early Phases of Multiple Sclerosis

  2022cites this paper
• BDNF Val66Met Polymorphism Is Associated With Motor Recovery After Rehabilitation in Progressive Multiple Sclerosis Patients

  2022cites this paper
• Emerging Biomarkers of Multiple Sclerosis in the Blood and the CSF: A Focus on Neurofilaments and Therapeutic Considerations

  2022cites this paper
• A Brief Overview on BDNF-Trk Pathway in the Nervous System: A Potential Biomarker or Possible Target in Treatment of Multiple Sclerosis?

  2022cites this paper
• The Brain-Derived Neurotrophic Factor Val66Met Polymorphism Can Protect Against Cognitive Impairment in Multiple Sclerosis

  2021cites this paper
• Effect of BDNF Val66Met polymorphism on hippocampal subfields in multiple sclerosis patients

  2021cites this paper
• Met carriers of the BDNF Val66Met polymorphism show reduced Glx/NAA in the pregenual ACC in two independent cohorts

  2021cites this paper
• IMPACT OF AEROBIC EXERCISE ON CLINICAL AND MAGNETIC RESONANCE IMAGING BIOMARKERS IN PERSONS WITH MULTIPLE SCLEROSIS: AN EXPLORATORY RANDOMIZED CONTROLLED TRIAL

  2021cites this paper
• BDNF Gene Frequency Distribution in Li and Han Ethnic Groups in Hainan Province and Its Comparison with Other Countries and Regions

  2020cites this paper
• Effect of Bromelain on BDNF level and memory deficit following intra-medial forebrain bundle 6-OHDA injection in rat model of Parkinsonism

  2020cites this paper
• Abstracts of the 51st Annual Conference of the Italian Society of Neurology

  2020cites this paper
• Interaction Between BDNF Val66Met and APOE4 on Biomarkers of Alzheimer’s Disease and Cognitive Decline

  2020cites this paper
• Protective Functions of Reactive Astrocytes Following Central Nervous System Insult

  2020cites this paper
• Glaucoma Sex-Specific Effect of BDNF Val 66 Met Genotypes on the Progression of Open-Angle Glaucoma

  2019cites this paper
• Sex-dependent effect of the BDNF Val66Met polymorphism on executive functioning and processing speed in older adults: evidence from the health ABC study.

  2019cites this paper
• Cognitive impairment in multiple sclerosis: An exploratory analysis of environmental and lifestyle risk factors

  2019cites this paper
• Sex-Specific Effect of BDNF Val66Met Genotypes on the Progression of Open-Angle Glaucoma.

  2019cites this paper
• The impact of brain‐derived neurotrophic factor Val66Met polymorphism on cognition and functional brain networks in patients with intractable partial epilepsy

  2018cites this paper
• Fronto-striatal plasticity processes in humans: glutamatergic and genetic mechanisms

  2018cites this paper
• BDNF Polymorphism: A Review of Its Diagnostic and Clinical Relevance in Neurodegenerative Disorders

  2018cites this paper
• BDNF rs6265 polymorphism methylation in Multiple Sclerosis: A possible marker of disease progression

  2018cites this paper
• The BDNF polymorphism Val66Met may be predictive of swallowing improvement post pharyngeal electrical stimulation in dysphagic stroke patients

  2017cites this paper
• Information processing speed in multiple sclerosis: Past, present, and future

  2017cites this paper
• Lack of neural compensatory mechanisms of BDNF val66met met carriers and APOE E4 carriers in healthy aging, mild cognitive impairment, and Alzheimer's disease.

  2016cites this paper
• Depression in multiple sclerosis: effect of brain derived neurotrophic factor Val66Met polymorphism and disease perception

  2016cites this paper
• Genetic variants and magnetic resonance imaging measures in multiple sclerosis: a systematic review

  2016cites this paper
• Genetic polymorphisms and the adequacy of brain stimulation: state of the art

  2016cites this paper
• No quiet surrender: molecular guardians in multiple sclerosis brain.

  2015cites this paper
• Brain structural alterations, genetic risk variants and the onset of psychosis

  2015cites this paper
• Cognitive reserve in multiple sclerosis: Protective effects of education

  2015cites this paper
• Imaging phenotypes in multiple sclerosis.

  2015cites this paper
• Effect of BDNF Val66Met polymorphism on regional white matter hyperintensities and cognitive function in elderly males without dementia.

  2014cites this paper
• Structural and functional cerebral changes in patients with schizophrenia and genetic risk-allele carriers

  2014cites this paper
• Paradoxical visuomotor adaptation to reversed visual input is predicted by BDNF Val66Met polymorphism.

  2014cites this paper
• Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis

  2014cites this paper
• Preservation of General Intelligence following Traumatic Brain Injury: Contributions of the Met66 Brain-Derived Neurotrophic Factor

  2014cites this paper
• Interdependence and contributions of sun exposure and vitamin D to MRI measures in multiple sclerosis

  2013cites this paper
• Multimodal imaging in systemic lupus erythematosus patients with diffuse neuropsychiatric involvement

  2013cites this paper
• Influence of Personality on the Relationship Between Gray Matter Volume and Neuropsychiatric Symptoms in Multiple Sclerosis

  2013cites this paper
• Effect of Age on MRI Phase Behavior in the Subcortical Deep Gray Matter of Healthy Individuals

  2013cites this paper
• MRI characteristics of familial and sporadic multiple sclerosis patients

  2013cites this paper
• The BDNF Val66Met Polymorphism Has Opposite Effects on Memory Circuits of Multiple Sclerosis Patients and Controls

  2013cites this paper
• Effects of the BDNF Val66Met Polymorphism on White Matter Microstructure in Healthy Adults

  2013influential citation
• Influence of BDNF polymorphisms on Wilson’s disease susceptibility and clinical course

  2013cites this paper
• Toward a unified biological hypothesis for the BDNF Val66Met-associated memory deficits in humans: a model of impaired dendritic mRNA trafficking

  2013cites this paper
• Brain-Derived Neurotrophic Factor in Neuroimmunology: Lessons Learned from Multiple Sclerosis Patients and Experimental Autoimmune Encephalomyelitis Models

  2013cites this paper
• BDNF-based synaptic repair as a disease-modifying strategy for neurodegenerative diseases

  2013cites this paper
• Iron Deposition on SWI-Filtered Phase in the Subcortical Deep Gray Matter of Patients with Clinically Isolated Syndrome May Precede Structure-Specific Atrophy

  2012cites this paper
• Associations of moderate alcohol consumption with clinical and MRI measures in multiple sclerosis.

  2012cites this paper
• Effect of BDNF val(66)met polymorphism on declarative memory and its neural substrate: a meta-analysis.

  2012cites this paper
• Iron deposition in multiple sclerosis lesions measured by susceptibility‐weighted imaging filtered phase: A case control study

  2012cites this paper
• Cine cerebrospinal fluid imaging in multiple sclerosis

  2012cites this paper
• The effect of BDNF val66met polymorphism on visuomotor adaptation

  2012cites this paper
• Polymorphisms of the BDNF gene show neither association with multiple sclerosis susceptibility nor clinical course.

  2012influential citation
• RELATIONSHIPS AMONG SYMPTOMS, BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF), DAILY ACTIVITIES, SELF-CARE, AND QUALITY OF LIFE IN BREAST CANCER SURVIVORS

  2012cites this paper
• No Association Between Conventional Brain MR Imaging and Chronic Cerebrospinal Venous Insufficiency in Multiple Sclerosis

  2012cites this paper
• Anti-phospholipid antibodies are associated with response to interferon-beta1a treatment in MS: results from a 3-year longitudinal study

  2012cites this paper
• Risk factors for and management of cognitive dysfunction in multiple sclerosis

  2011cites this paper
• Brain-derived neurotrophic factor (BDNF) gene: a gender-specific role in cognitive function during normal cognitive aging of the MEMO-Study?

  2011cites this paper
• Hypoperfusion of brain parenchyma is associated with the severity of chronic cerebrospinal venous insufficiency in patients with multiple sclerosis: a cross-sectional preliminary report

  2011cites this paper
• Effect of Met66 allele of the BDNF rs6265 SNP on regional gray matter volumes in patients with multiple sclerosis: A voxel-based morphometry study.

  2011cites this paper
• HLA DRB1*1501 is only modestly associated with lesion burden at the first demyelinating event.

  2011cites this paper
• The rs2030324 SNP of brain-derived neurotrophic factor (BDNF) is associated with visual cognitive processing in multiple sclerosis.

  2011cites this paper
• Basal ganglia, thalamus and neocortical atrophy predicting slowed cognitive processing in multiple sclerosis

  2011cites this paper
• Glatiramer acetate recovers microscopic tissue damage in patients with multiple sclerosis. A case-control diffusion imaging study.

  2011cites this paper
• The Role of the Met66 Brain-Derived Neurotrophic Factor Allele in the Recovery of Executive Functioning after Combat-Related Traumatic Brain Injury

  2011cites this paper
• Cortical surface and volume extraction through two-phase fast marching method

  2011cites this paper
• Information processing speed, neural efficiency, and working memory performance in multiple sclerosis: Differential relationships with structural magnetic resonance imaging

  2011cites this paper
• Behavioral / Systems / Cognitive The Role of the Met 66 Brain-Derived Neurotrophic Factor Allele in the Recovery of Executive Functioning after Combat-Related Traumatic Brain Injury

  2011cites this paper
• BDNF Val66Met polymorphism and brain volumes in multiple sclerosis

  2011cites this paper
• Chronic cerebrospinal venous insufficiency and iron deposition on susceptibility-weighted imaging in patients with multiple sclerosis: a pilot case-control study.

  2010cites this paper
• Increased tissue damage and lesion volumes in African Americans with multiple sclerosis

  2010cites this paper
• BDNF val66met polymorphism influences motor system function in the human brain.

  2010cites this paper
• Vitamin D metabolites are associated with clinical and MRI outcomes in multiple sclerosis patients

  2010cites this paper
• The link between inflammation, synaptic transmission and neurodegeneration in multiple sclerosis

  2010cites this paper
• The effects of BDNF Val66Met polymorphism on brain function in controls and patients with multiple sclerosis: an imaging genetic study.

  2010cites this paper
• CSF dynamics and brain volume in multiple sclerosis are associated with extracranial venous flow anomalies: a pilot study.

  2010cites this paper
• Magnetic resonance imaging characteristics of children and adults with paediatric-onset multiple sclerosis.

  2009cites this paper
• A longitudinal observation of brain-derived neurotrophic factor mRNA levels in patients with relapsing-remitting multiple sclerosis.

  2009cites this paper
• Function of neurotrophic factors beyond the nervous system: inflammation and autoimmune demyelination.

  2009cites this paper
• Brain imaging of multiple sclerosis: the next 10 years.

  2009cites this paper
• Brain-derived neurotrophic factor and TrkB receptor in experimental autoimmune encephalomyelitis and multiple sclerosis.

  2009cites this paper
• Relationship of optic nerve and brain conventional and non-conventional MRI measures and retinal nerve fiber layer thickness, as assessed by OCT and GDx: a pilot study.

  2009cites this paper
• MRI characteristics of patients with antiphospholipid syndrome and multiple sclerosis

  2009cites this paper
• Correlations between peripheral blood mononuclear cell production of BDNF, TNF‐alpha, IL‐6, IL‐10 and cognitive performances in multiple sclerosis patients

  2009cites this paper
• Gender-related differences in MS: a study of conventional and nonconventional MRI measures

  2009cites this paper
• Memory impairment in multiple sclerosis: correlation with deep grey matter and mesial temporal atrophy

  2008cites this paper